User:S4289005: Difference between revisions

From MicrobeWiki, the student-edited microbiology resource
Line 58: Line 58:
==Application to biotechnology==
==Application to biotechnology==


Bioengineering, biotechnologically relevant enzyme/compound production, drug targets,
P. gingivalis generally relies upon teeth for colonisation of the mouth, and is strictly anaerobic, therefore it exists as a very specialised bacteria in the oral cavity (7). On account of this, as well as their metabolic requirements, they are difficult to culture in large numbers. They do not make any commercially relevant metabolic products, therefore most of the bipotechnology surrounding this species is aimed at removing them from periodontitis patients, rather than utilising them for production. There are currently a number of chemical treatments available which can target P. gingivalis, but most of these result in undesirable side effects such as vomiting or tooth-staining (14). As a result there is an increasing demand for naturally produced biomaterials which are biocompatible, biodegradable, and do not produce undesirable side effects. There are a number of materials such as hydrogels, which fit this role and additionally can be chemically modified or loaded with drugs in order to slowly release the treatment (15). One of the major materials being investigated for this application is chitosan, it displays a number of desirable characteristics such as biodegradability, and antimicrobial properties (14). Pullulan is another naturally formed compound being investigated, as it is already being used in some dental care products (14).
 
Extensive research seems to indicate genetically modified P. gingivalis has never been used to produce useful bacterial products. Furthermore there is no evidence that any of the unique cellular products from P. gingivalis have ever been converted into a useful technology. Therefore, the only biotechnology relevant to P. gingivalis, is technology targeted at the bacteria. In addition to the compounds mentioned previously, there are a number of other research projects for detecting P. gingivalis, such as by using nanobodies (16).


==Current research==
==Current research==

Revision as of 05:23, 23 September 2016

Thomas Clarkson, Bench D, 31/08/16.


Classification

re re re

Higher order taxa

Bacteria – Bacteria – Bacteroidetes – Bacteroidetes – Bacteroidales – Porphyromonas - gingivalis

Species

The species is Porphyromonas gingivalis, and it has a number of different type strains. These are 2561 T , ATCC 33277 T , BCRC 14417 T , CCRC 14417 T , CCUG 25893 T , CCUG 25928 T , CIP 103683 T , Coykendall 2561T , DSM 20709 T , JCM 12257 T , KCTC 5121T , NCTC 11834 T , Slots 2561 T , Slots' 2561 T , Slots' strain 2561 T (1).

' 'it is a strain[1]

or is it a strain?[1]

Description and significance

Porphyromonas gingivalis, is a gram-negative rod bacteria. It is non-motile, and found on and within the gingival epithelial cells in the oral cavity. It is dark-pigmented, asaccharolytic, and requires iron from heme for growth (2). Its relative importance comes from its implication as the most common cause of periodontitis. A number of articles have demonstrated its role as the aetiological agent. Overall, around 85% of diseased tissues have been shown to house P. gingivalis (2). Additionally it is not often found in healthy tissue, and the depth of the surface pits it forms from infection is strongly correlated to numbers of P. gingivalis present at the site (2). The bacteria cannot be found in the environment, due to its specific metabolic requirements, It can however be cultured on a blood agar plate (2).

Genome structure

The P. Gingivalis strain, 2561T has a total of 41 sequences in its genome (1). The longest among these is 9878 base pairs long and codes for a DnaK operon, the total genome is 2354886 base pairs long (1). Of these genes, 6 of them are related to 16RNA in some form. A number of the others DNA sequences are related to the virulence factors required for pathology, particularly fimbriae for which 7 of the genes code for (1). A literature review found no evidence of plasmids of any sort within the genome of P. gingivalis. Furthermore, it was confirmed that they have no cryptic plasmids, however researchers have succeeded in introducing plasmids to their genome (3). Other researchers sequenced the entire genome of strain TDC60, which is a particularly virulent strain, and found that it had a single circular genome 2339898 bp long, indicating no plasmids were present (4).

Cell structure and metabolism

P. gingivalis is a gram negative, rod-shaped bacteria. As a result it has a thinner cell wall with an outer membrane largely composed of LPS. It is also an obligate anaerobe. On account of this, as well as its niche environment on the gingiva, it has a number of adapted metabolic pathways to enable growth. One of the main features is that it requires iron from heme for growth, which it can sequester from its host using gingipains (5). Additionally, P. gingivalis cannot grow without vitamin K. the bacteria is asaccharoltyic, meaning that it can’t break down sugars. This is not necessary because the environments it lives in are often lacking in sugars. Such as within the pits it forms, at the bottom of which minimal sugars are present, therefore it produces energy by breaking down amino acids (2).

Ecology

P. gingivalis makes up a major component of the human oral microbiome, and has successfully colonised the epithelial cells of the gingiva(6). It is a compulsively anaerobic species, so cannot survive in the presence of oxygen. It can often be found in what is termed a ‘red complex’ in conjunction with Treponema denticola, and Tannerella forsythia. This complex is strongly associated with periodontal disease (7). Despite its well-researched connection with PATHOLOGY, P. gingivalis is found in numbers of patients not displaying clinical pathology (6). In general, bacteria colonising the mouth are tolerant towards and tolerated by the immune system, because inflammation leading to loss of teeth will eventually kill both the host and the bacteria (8). This is why some of the bacteria do not produce a negative reaction in the host. P. gingivalis colonises epithelial cells in the gingival compartment, which sometimes detect the bacteria and release inflammatory cytokines, however no particular apoptosis is noted in colonised cells (6). The bacteria is able to adhere to the epithelial cells due to its fimbriae, and enter the cells by binding to the β1 integrin receptor (6). It is capable of intracellular replication. Infected cells as with colonised cells do not display apoptosis, as the typical apoptotic pathways are inhibited by P. gingivalis while it replicates. In this way the bacteria is able to maintain viability within the epithelial cells for large amounts of time (6). The mouth seems to be the only habitat that this bacteria can survive in, as there is no evidence of free-living P. gingivalis (8). This makes sense, as the bacteria has very restrictive metabolic requirements. It is also suggested that the surface of the tooth may be required for colonisation, which is another factor reducing the ability of P. gingivalis to replicate outside the oral cavity. The evidence supporting this hypothesis is that the bacteria has not been cultured from edentulous babies or elderly (8). Other mammalian species are colonised by P. gingivalis, however the strains are genetically dissimilar and distinct.

Pathology

P. gingivalis is able to causes disease in humans due to a number of virulence factors allowing it to evade the immune system and colonise regions within the host. It has three main categories of virulence factors: colonisation, host evasion, and host attacking (5). Below is a list of the different virulence factors for each (5): Colonisation: - Fimbriae (Also important in evading host) - Hemagglutinin - Outer membrane proteins - Gingipains (help sequester iron and promote bacterial growth) Evading Host: - Capsule (antigenic and phase variation makes an acquired immune response difficult) - LPS (a potent immunogenic endotoxin) - Complement Proteases (reduce the effectiveness of a complement immune response) - biofilm Damaging Host: - Proteinases - Collagenase - Lytic enzymes

These virulence factors, combined with the predisposition of P. gingivalis for colonising the gingiva can often result in periodontitis. This is a disease for which P. gingivalis has been heavily implicated. Periodontitis is a disease which results in the degradation of supporting periodontal tissues, this leads to poor attachment of the enamel to bone (9). This reduced connection means that patients often experience tooth loss. This is the main observed form of pathology resulting from P. gingivalis infections. The cause of this degradation is chronic inflammation, which attacks the gingiva, the periodontal ligament, and the alveolar bone which connects the jaw to the teeth (10). Periodontitis is essentially an extreme form of gingivitis, which a large portion of the population experiences. Gingivitis presents as light inflammation of the gingiva. In periodontitis the inflammation goes much deeper into the tissue, resulting in the formation of deep pits filled with P. gingivalis. It is this inflammation which attacks the gingival support structures around the teeth. The resultant breakdown of fibre and resorption of alveolar bones can lead to the movement and loss of teeth (10).

Researchers have found that there is a connection between P. gingivalis causing periodontitis and type II diabetes (10, 11). However it is postulated this connection is only because type II diabetes results in susceptibility to P gingivalis infections. Other researchers have found possible connections between P. gingivalis and other diseases such as cardiovascular disease and artherosclerosis (12). Borgnakke et al. (2013) surveyed a great deal of literature with the proposal that periodontitis is often connected to general health of the patient, their search uncoverered a great deal of information to suggest that this might be the case (13). The formation of a biofilm by this bacteria is of significance to its virulence, and this is considered to be a potential target for therapeutic treatment (7). LPS also plays a large role in the development of periodontitis, interaction with cells in peridontic lesions leads to a large immune response as LPS is a potent endotoxin and highly immunogenic (7).

Application to biotechnology

P. gingivalis generally relies upon teeth for colonisation of the mouth, and is strictly anaerobic, therefore it exists as a very specialised bacteria in the oral cavity (7). On account of this, as well as their metabolic requirements, they are difficult to culture in large numbers. They do not make any commercially relevant metabolic products, therefore most of the bipotechnology surrounding this species is aimed at removing them from periodontitis patients, rather than utilising them for production. There are currently a number of chemical treatments available which can target P. gingivalis, but most of these result in undesirable side effects such as vomiting or tooth-staining (14). As a result there is an increasing demand for naturally produced biomaterials which are biocompatible, biodegradable, and do not produce undesirable side effects. There are a number of materials such as hydrogels, which fit this role and additionally can be chemically modified or loaded with drugs in order to slowly release the treatment (15). One of the major materials being investigated for this application is chitosan, it displays a number of desirable characteristics such as biodegradability, and antimicrobial properties (14). Pullulan is another naturally formed compound being investigated, as it is already being used in some dental care products (14).

Extensive research seems to indicate genetically modified P. gingivalis has never been used to produce useful bacterial products. Furthermore there is no evidence that any of the unique cellular products from P. gingivalis have ever been converted into a useful technology. Therefore, the only biotechnology relevant to P. gingivalis, is technology targeted at the bacteria. In addition to the compounds mentioned previously, there are a number of other research projects for detecting P. gingivalis, such as by using nanobodies (16).

Current research

Summarise some of the most recent discoveries regarding this species.

References

References examples

1. Sahm, K., MacGregor, B.J., Jørgensen, B.B., and Stahl, D.A. (1999) Sulphate reduction and vertical distribution of sulphate-reducing bacteria quantified by rRNA slotblot hybridization in a coastal marine sediment. Environ Microbiol 1: 65-74.

2. Human Oral Microbiome

3. Honda, T., Takahashi, N., Miyauchi, S., yamazaki, K. (2012) Porphyromonas gingivalis lipopolysaccharide induces miR-146a without altering the production of inflammatory cytokines. Biochemical and Biophysical Research Communications 2.

NOTE DO NOT REFERENCE LIKES THIS, USE THE FIRST THREE REFERENCES, AND ALSO FOR CITATIONS USE THE SUPERSCRIPT COMMAND

This page is written by Thomas Clarkson for the MICR3004 course, Semester 2, 2016